Rydapt

Rydapt Indications/Uses

midostaurin

Manufacturer:

Novartis

Distributor:

Zuellig Pharma
Full Prescribing Info
Indications/Uses
RYDAPT is indicated: in combination with standard daunorubicin and cytarabine induction and high-dose cytarabine consolidation chemotherapy, and for patients in complete response followed by Rydapt single agent maintenance therapy, for adult patients with newly diagnosed acute myeloid leukaemia (AML) who are FLT3 mutation-positive.
For the treatment of adult patients with advanced systemic mastocytosis (Advanced SM).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in